118 related articles for article (PubMed ID: 6330851)
21. Experience of vaccination with inactivated poliomyelitis vaccines in Iceland.
Gudnadóttir M
Dev Biol Stand; 1981; 47():257-9. PubMed ID: 7227654
[TBL] [Abstract][Full Text] [Related]
22. [Global eradication of poliomyelitis. On the 80th anniversary of the founding of the National Institute of Health].
Slonim D
Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):99-108. PubMed ID: 16173520
[TBL] [Abstract][Full Text] [Related]
23. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
24. World wide experience with inactivated poliovirus vaccine.
Bonnet MC; Dutta A
Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
[TBL] [Abstract][Full Text] [Related]
25. [The use of inactivated polio vaccine to prevent polio paralysis associated with the vaccination of children living in orphanages].
Ion-Nedelcu N; Crăciun D; Strebel P; Ciufecu C
Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):243-8. PubMed ID: 9586335
[No Abstract] [Full Text] [Related]
26. [The perspective of global eradication of poliomyelitis].
Knolle H; Egli A; Candrian U
Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
[TBL] [Abstract][Full Text] [Related]
27. ['Open season in the hunt for poliovirus' (continued)].
van Loon AM; van der Avoort HG
Ned Tijdschr Geneeskd; 1997 Jul; 141(29):1420-4. PubMed ID: 9542865
[TBL] [Abstract][Full Text] [Related]
28. Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission.
Aylward RB; Cochi SL
Bull World Health Organ; 2004 Jan; 82(1):40-6. PubMed ID: 15106299
[TBL] [Abstract][Full Text] [Related]
29. Results of a program successfully combining live and killed polio vaccines.
Lasch EE; Abed Y; Gerichter CB; Massri ME; Marcus O; Hensher R; Goldblum N
Isr J Med Sci; 1983 Nov; 19(11):1021-3. PubMed ID: 6662685
[TBL] [Abstract][Full Text] [Related]
30. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
31. A case for developing antiviral drugs against polio.
Collett MS; Neyts J; Modlin JF
Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
[TBL] [Abstract][Full Text] [Related]
32. [Poliomyelitis--why we must continue to vaccinate!].
Windorfer A; Beyrer K
MMW Fortschr Med; 2005 Feb; 147(8):36, 38, 40. PubMed ID: 18437859
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of poliomyelitis--options and update.
Dutta A
Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
[TBL] [Abstract][Full Text] [Related]
34. A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine.
Wood DJ; Heath AB; Kersten GF; Hazendonk T; Lantinga M; Beuvery EC
Biologicals; 1997 Mar; 25(1):59-64. PubMed ID: 9167009
[TBL] [Abstract][Full Text] [Related]
35. Possible global strategies for stopping polio vaccination and how they could be harmonized.
Cochi SL; Sutter RW; Aylward RB
Dev Biol (Basel); 2001; 105():153-8; discussion 159. PubMed ID: 11763323
[TBL] [Abstract][Full Text] [Related]
36. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
[TBL] [Abstract][Full Text] [Related]
37. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
[TBL] [Abstract][Full Text] [Related]
38. Concentration and purification of poliovirus by immune adsorption on immobilized antibodies.
van der Marel P; van Wezel AL; Hazendonk AG; Kooistra A
Dev Biol Stand; 1980; 46():267-73. PubMed ID: 6245002
[TBL] [Abstract][Full Text] [Related]
39. Classics in infectious diseases. The cultivation of the poliomyelitis viruses in tissue culture by John F. Enders, Frederick C. Robbins, and Thomas H. Weller.
Enders JF; Robbins FC; Weller TH
Rev Infect Dis; 1980; 2(3):493-504. PubMed ID: 6251529
[No Abstract] [Full Text] [Related]
40. Potency testing for killed poliomyelitis vaccine.
Beale AJ
Dev Biol Stand; 1981; 47():69-75. PubMed ID: 6262161
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
